PTAB
Advanced fields
299 decisions · 433msnewest first
  • PTAB · Aug 14, 2025 · IPR2025-00655 · APJ Coke Morgan Stewart · IPR · Director review

    The Director granted Patent Owner’s discretionary-denial request and denied institution of IPR on the challenged patent under § 314(a), based on the holistic assessment.

    RulingsDirector review decision
    • Settled expectationsInstitution denied settled expectationsDenied

      “wholly owned subsidiary of Petitioner, owned and maintained the challenged patents from 2015 until 2021. DD Opp. 4, 6; Ex. 1034; Paper 10, 1. Nuance further retained a license upon selling the patent that extended to its customers. DD Opp. 4, 6. Absent exceptional circumstances, it is not an appropriate use of Office resources where a party’s wholly owned subsidiary owned, maintained, sold, and retained a license for a patent, but, as is the case here, the party now advocates for its unpatentability. See Analog Devices, Inc. v. Number 14 B.V., IPR2025-00550, Paper 10 at 2 (Director July 16, 2025). Additionally, the challenged patents have been in force for more than fifteen, twelve, nine, thirteen, and eight years, respectively, creating strong settled expectations for Patent Owner, and Petitioner does not provide any persuasive reasoning why an inter partes review is an 1 Citations are to papers in IPR2025-00655. The parties filed similar papers in IPR2025-00656, IPR2025-00657, IPR2025-00658, and IPR2025-00659. appropriate use of Board resources. Dabico Airport Sols. Inc. v. AXA Power ApS, IPR2025-00408, Paper 21 at 2–3 (Director June 18, 2025).” slip op. at 2

    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivDenied

      “Furthermore, one of Petitioner’s real-parties-in-interest, Bank of America, N.A., is a party to a parallel district court proceeding that involves the same challenged patents, the same challenged claims, and significantly overlapping invalidity contentions as these IPR proceedings. DD. Req. 15– 16; see Ex. 2003, 3, 60–76. The projected final written decision due date in these Board proceedings is in October 2026. DD Req. 6. The district court’s scheduled trial date is May 4, 2026. DD Opp. 15–16. As such, it is unlikely that a final written decision in these proceedings will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. This additionally weighs in favor of discretionary denial.” slip op. at 3

    • Other 314aInstitution denied discretionary otherDenied

      “Although certain arguments are highlighted above, the determination to exercise discretion to deny institution is based on a holistic assessment of all of the evidence and arguments presented. Accordingly, the Petitions are denied under 35 U.S.C. § 314(a). In consideration of the foregoing, it is: ORDERED that Patent Owner’s request for discretionary denial is granted; and FURTHER ORDERED that the Petitions are denied, and no trial is instituted.” slip op. at 3

    Discretionary denial
    Patents in suitUS 7,640,160
  • PTAB · Aug 14, 2025 · IPR2025-00781 · APJ Kalyan K Deshpande · IPR · Director review

    The Director granted Patent Owner’s discretionary-denial request and denied the petitions under § 314(a), instituting no trial because district-court trial would likely precede the final written decisions and settled expectations favored denial.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivDenied

      “In particular, the projected final written decision due date for each of these cases is October 18, 2026. The district court’s scheduled trial date is April 20, 2026, and the time-to-trial statistics suggest trial will begin by January 2026. DD Req. 6. As such, it is unlikely that a final written decision in these proceedings will issue before the district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, there is insufficient evidence that the district court is likely to stay its proceeding even if the Board were to institute trial. Id. at 3–11.” slip op. at 2

    • Settled expectationsInstitution denied settled expectationsDenied

      “Further, the challenged patents have been in force for approximately eight and six years, creating strong settled expectations for Patent Owner, and Petitioner does not provide any persuasive reasoning why an inter partes review is an appropriate use of Board resources. Dabico Airport Sols. Inc. v. AXA Power ApS, IPR2025-00408, Paper 21 at 2–3 (Director June 18, 2025).” slip op. at 2

    Discretionary denial
    Patents in suitUS 10,200,227
  • PTAB · Aug 14, 2025 · IPR2025-00780 · APJ Kalyan K Deshpande · IPR · Director review

    The Director granted Patent Owner’s discretionary-denial request and denied the petitions without instituting trial under § 314(a), based on parallel litigation and settled expectations.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivDenied

      “In particular, the projected final written decision due date for each of these cases is October 18, 2026. The district court’s scheduled trial date is April 20, 2026, and the time-to-trial statistics suggest trial will begin by January 2026. DD Req. 6. As such, it is unlikely that a final written decision in these proceedings will issue before the district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, there is insufficient evidence that the district court is likely to stay its proceeding even if the Board were to institute trial. Id. at 3–11.” slip op. at 2

    • Settled expectationsInstitution denied settled expectationsDenied

      “Further, the challenged patents have been in force for approximately eight and six years, creating strong settled expectations for Patent Owner, and Petitioner does not provide any persuasive reasoning why an inter partes review is an appropriate use of Board resources. Dabico Airport Sols. Inc. v. AXA Power ApS, IPR2025-00408, Paper 21 at 2–3 (Director June 18, 2025).” slip op. at 2

    Discretionary denial
    Patents in suitUS 9,768,842
  • PTAB · Aug 14, 2025 · IPR2025-00644 · APJ Kalyan K Deshpande · IPR · Director review

    The Director granted Patent Owner’s discretionary-denial request and denied institution under § 314(a) because district court trial is expected first and settled expectations favor denial.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivDenied

      “In particular, the projected final written decision due date in the Board proceedings is October 16, 2026. DD Req. 4–5. The district court’s scheduled trial date is April 6, 2026, and the time-to-trial statistics suggest trial will begin in May or June of 2026. Id. at 4; DD Opp. 8; Ex. 1050. As such, it is unlikely that a final written decision in these proceedings will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, the patents challenged in IPR2025-00639, IPR2025-00640, IPR2025-00642, IPR2025-00643, and IPR2025-00644 have been in force for over nine, eight, twelve, nine, and nine years, respectively, creating strong settled expectations for Patent Owner.” slip op. at 2

    • Settled expectationsInstitution denied settled expectationsDenied

      “proceedings is October 16, 2026. DD Req. 4–5. The district court’s scheduled trial date is April 6, 2026, and the time-to-trial statistics suggest trial will begin in May or June of 2026. Id. at 4; DD Opp. 8; Ex. 1050. As such, it is unlikely that a final written decision in these proceedings will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, the patents challenged in IPR2025-00639, IPR2025-00640, IPR2025-00642, IPR2025-00643, and IPR2025-00644 have been in force for over nine, eight, twelve, nine, and nine years, respectively, creating strong settled expectations for Patent Owner.” slip op. at 2

    • PTAB / AIA Trials › Institution threshold (reasonable likelihood / more likely than not)Institution denied discretionary otherInstitution denied

      “Although certain arguments are highlighted above, the determination to exercise discretion to deny institution is based on a holistic assessment of all of the evidence and arguments presented. Accordingly, the Petitions are denied under 35 U.S.C. § 314(a). In consideration of the foregoing, it is: ORDERED that Patent Owner’s request for discretionary denial is granted; and FURTHER ORDERED that the Petitions are denied, and no trial is instituted.” slip op. at 3

    Discretionary denial
    Patents in suitUS 9,208,423
  • PTAB · Aug 14, 2025 · IPR2025-00642 · APJ Kalyan K Deshpande · IPR · Director review

    The Director granted Patent Owner’s discretionary-denial request and denied the petitions under § 314(a), instituting no trial.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivInstitution denied

      “In particular, the projected final written decision due date in the Board proceedings is October 16, 2026. DD Req. 4–5. The district court’s scheduled trial date is April 6, 2026, and the time-to-trial statistics suggest trial will begin in May or June of 2026. Id. at 4; DD Opp. 8; Ex. 1050. As such, it is unlikely that a final written decision in these proceedings will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, the patents challenged in IPR2025-00639, IPR2025-00640, IPR2025-00642, IPR2025-00643, and IPR2025-00644 have been in force for over nine, eight, twelve, nine, and nine years, respectively, creating strong settled expectations for Patent Owner.” slip op. at 2

    • Settled expectationsInstitution denied settled expectationsInstitution denied

      “proceedings is October 16, 2026. DD Req. 4–5. The district court’s scheduled trial date is April 6, 2026, and the time-to-trial statistics suggest trial will begin in May or June of 2026. Id. at 4; DD Opp. 8; Ex. 1050. As such, it is unlikely that a final written decision in these proceedings will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, the patents challenged in IPR2025-00639, IPR2025-00640, IPR2025-00642, IPR2025-00643, and IPR2025-00644 have been in force for over nine, eight, twelve, nine, and nine years, respectively, creating strong settled expectations for Patent Owner.” slip op. at 2

    Discretionary denial
    Patents in suitUS 8,403,219
  • PTAB · Aug 14, 2025 · IPR2025-00640 · APJ Kalyan K Deshpande · IPR · Director review

    The Director denied institution of IPR challenging the patent under § 314(a), citing the district court schedule, risk of duplication, and Patent Owner’s settled expectations.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Denied

      “In particular, the projected final written decision due date in the Board proceedings is October 16, 2026. DD Req. 4–5. The district court’s scheduled trial date is April 6, 2026, and the time-to-trial statistics suggest trial will begin in May or June of 2026. Id. at 4; DD Opp. 8; Ex. 1050. As such, it is unlikely that a final written decision in these proceedings will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, the patents challenged in IPR2025-00639, IPR2025-00640, IPR2025-00642, IPR2025-00643, and IPR2025-00644 have been in force for over nine, eight, twelve, nine, and nine years, respectively, creating strong settled expectations for Patent Owner.” slip op. at 2

    • Settled expectationsDenied

      “proceedings is October 16, 2026. DD Req. 4–5. The district court’s scheduled trial date is April 6, 2026, and the time-to-trial statistics suggest trial will begin in May or June of 2026. Id. at 4; DD Opp. 8; Ex. 1050. As such, it is unlikely that a final written decision in these proceedings will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, the patents challenged in IPR2025-00639, IPR2025-00640, IPR2025-00642, IPR2025-00643, and IPR2025-00644 have been in force for over nine, eight, twelve, nine, and nine years, respectively, creating strong settled expectations for Patent Owner.” slip op. at 2

    Discretionary denial
    Patents in suitUS 9,483,722
  • PTAB · Aug 14, 2025 · IPR2025-00639 · APJ Kalyan K Deshpande · IPR · Director review

    The Petitions were denied under § 314(a) because district court trial is expected before a final written decision, creating duplication and inconsistent-decision risks, and settled expectations favor denial.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivInstitution denied

      “In particular, the projected final written decision due date in the Board proceedings is October 16, 2026. DD Req. 4–5. The district court’s scheduled trial date is April 6, 2026, and the time-to-trial statistics suggest trial will begin in May or June of 2026. Id. at 4; DD Opp. 8; Ex. 1050. As such, it is unlikely that a final written decision in these proceedings will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, the patents challenged in IPR2025-00639, IPR2025-00640, IPR2025-00642, IPR2025-00643, and IPR2025-00644 have been in force for over nine, eight, twelve, nine, and nine years, respectively, creating strong settled expectations for Patent Owner.” slip op. at 2

    • Settled expectationsInstitution denied settled expectationsInstitution denied

      “proceedings is October 16, 2026. DD Req. 4–5. The district court’s scheduled trial date is April 6, 2026, and the time-to-trial statistics suggest trial will begin in May or June of 2026. Id. at 4; DD Opp. 8; Ex. 1050. As such, it is unlikely that a final written decision in these proceedings will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, the patents challenged in IPR2025-00639, IPR2025-00640, IPR2025-00642, IPR2025-00643, and IPR2025-00644 have been in force for over nine, eight, twelve, nine, and nine years, respectively, creating strong settled expectations for Patent Owner.” slip op. at 2

    • Other 314aInstitution denied discretionary otherInstitution denied

      “The patents challenged in IPR2025-00641 and IPR2025-00645 have not been in force as long as the other patents challenged. While ordinarily such circumstances might counsel against discretionary denial, the district court will be considering the validity of the patents challenged in IPR2025- 00639, IPR2025-00640, IPR2025-00642, IPR2025-00643, and IPR2025- 00644, along with the validity of the patents challenged in IPR2025-00641 and IPR2025-00645, and referring IPR2025-00641 and IPR2025-00645 to the Board would be an inefficient use of Board resources and tips the balance to discretionary denial as to those patent too. Although certain arguments are highlighted above, the determination to exercise discretion to deny institution is based on a holistic assessment of all of the evidence and arguments presented. Accordingly, the Petitions are denied under 35 U.S.C. § 314(a).” slip op. at 3

    Discretionary denial
    Patents in suitUS 9,122,965
  • PTAB · Aug 14, 2025 · IPR2025-00544 · APJ Kalyan K Deshpande · IPR · Director review

    The Director denied institution of IPR, finding discretionary denial appropriate based on the projected district court trial timing, risk of duplication, and Patent Owner’s settled expectations.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Denied

      “In particular, the projected final written decision due date for each of these cases is in October 2026. DD Req. 30. The district court’s scheduled trial date is April 20, 2026, and the time-to-trial statistics suggest that trial would begin by August 2026. Id. at 30–31; DD Opp. 47; Ex. 1052, 35. As such, it is unlikely that a final written decision in these proceedings will issue before the district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, there is insufficient evidence that the district court is likely to stay its proceeding even if the Board were to institute trial.” slip op. at 2

    • Settled expectationsDenied

      “Further, the challenged patents have been in force for approximately ten, ten, eight, and eight years, respectively, creating strong settled expectations for Patent Owner.” slip op. at 3

    • Director reviewInstitution denied settled expectationsInstitution denied

      “Although certain arguments are highlighted above, the determination to exercise discretion to deny institution is based on a holistic assessment of all of the evidence and arguments presented. Accordingly, the Petitions are denied under 35 U.S.C. § 314(a). In consideration of the foregoing, it is: ORDERED that Patent Owner’s requests for discretionary denial are granted; and FURTHER ORDERED that the Petitions are denied, and no trial is instituted.” slip op. at 3

    Discretionary denial
    Patents in suitUS 9,619,578
  • PTAB · Aug 14, 2025 · IPR2025-00543 · APJ Kalyan K Deshpande · IPR · Director review

    The Director denied institution under § 314(a), finding that the district court trial likely would precede the final written decision and that the patents’ age created strong settled expectations.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivInstitution denied

      “In particular, the projected final written decision due date for each of these cases is in October 2026. DD Req. 30. The district court’s scheduled trial date is April 20, 2026, and the time-to-trial statistics suggest that trial would begin by August 2026. Id. at 30–31; DD Opp. 47; Ex. 1052, 35. As such, it is unlikely that a final written decision in these proceedings will issue before the district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, there is insufficient evidence that the district court is likely to stay its proceeding even if the Board were to institute trial.” slip op. at 2

    • Settled expectationsInstitution denied settled expectationsInstitution denied

      “Further, the challenged patents have been in force for approximately ten, ten, eight, and eight years, respectively, creating strong settled expectations for Patent Owner. Although certain arguments are highlighted above, the determination to exercise discretion to deny institution is based on a holistic assessment of all of the evidence and arguments presented. Accordingly, the Petitions are denied under 35 U.S.C. § 314(a).” slip op. at 3

    Discretionary denial
    Patents in suitUS 9,619,578
  • PTAB · Aug 14, 2025 · IPR2025-00542 · APJ Kalyan K Deshpande · IPR · Director review

    The Director denied institution under § 314(a), finding that the district court trial would likely precede the final written decision and settled expectations favored denial.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Denied

      “In particular, the projected final written decision due date for each of these cases is in October 2026. DD Req. 30. The district court’s scheduled trial date is April 20, 2026, and the time-to-trial statistics suggest that trial would begin by August 2026. Id. at 30–31; DD Opp. 47; Ex. 1052, 35. As such, it is unlikely that a final written decision in these proceedings will issue before the district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, there is insufficient evidence that the district court is likely to stay its proceeding even if the Board were to institute trial.” slip op. at 2

    • Settled expectationsDenied

      “Further, the challenged patents have been in force for approximately ten, ten, eight, and eight years, respectively, creating strong settled expectations for Patent Owner. Although certain arguments are highlighted above, the determination to exercise discretion to deny institution is based on a holistic assessment of all of the evidence and arguments presented. Accordingly, the Petitions are denied under 35 U.S.C. § 314(a).” slip op. at 3

    Discretionary denial
    Patents in suitUS 9,922,348

Holdings, summaries, rulings, issues, outcomes, winners and claim constructions shown for a decision were generated by a large language model reading the opinion. They are a guide to the decision, not the decision. Confirm every one against the court's own text before relying on it. Outcomes read from the patent owner’s side. Party names are extracted from the decision and are missing on about 900 short Director denials and scans, which carry the trial number instead.